Therapeutics Acquisition Corp.
200 Berkeley Street, 18th Floor
Boston, MA 02116
June 8, 2021
VIA EDGAR
Mr. Eric Atallah
Mr. Brian Cascio
Ms. Abby Adams
Mr. Chris Edwards
Office of Life Sciences
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Therapeutics Acquisition Corp. |
Acceleration Request for Registration Statement on Form S-4 | |
File No. 333-333-254600 |
Requested Date: | June 9, 2021 | |
Requested Time: | 4:30 p.m. Eastern Standard Time |
Dear Ms. Atallah, Mr. Cascio, Ms. Adams and Mr. Edwards:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Therapeutics Acquisition Corp. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to June 9, 2021, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling Laurie Burlingame at (617) 570-1879. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: Laurie Burlingame, by email at LBurlingame@goodwinlaw.com.
[Remainder of page left intentionally blank]
If you have any questions regarding this request, please contact Laurie Burlingame of Goodwin Procter LLP at (617) 570-1879.
Sincerely, | |
Therapeutics Acquisition Corp.. | |
/s/ Matthew Hammond | |
Matthew Hammond | |
Chief Financial Officer |
cc: | Laurie Burlingame, Esq., Goodwin Procter LLP Daniel Espinoza, Esq., Goodwin Procter LLP Blake Liggio, Esq., Goodwin Procter LLP Jocelyn Arel, Esq., Goodwin Procter LLP Jay Knight, Esq., Bass, Berry & Sims PLC Susan Sidwell, Esq., Bass, Berry & Sims PLC |